Trial Profile

APPRECIATE (Apremilast Clinical Treatment Experience in Psoriasis): A Multi-center, Retrospective Observational Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Mar 2023 Status changed from recruiting to completed.
02 Mar 2023 Results (n=50 from Croatia, Czech Republic and Slovenia) assessing efficacy of apremilast in Severe Psoriasis on the real-world use of apremilast in the Central and Eastern Europe region published in the Advances in Therapy
02 Jul 2021 Planned End Date changed from 30 Apr 2021 to 29 Oct 2021.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com